MAOA and major depressive disorder: Differently, Yoshida et al. [55] could not establish an association between plasma drug levels and MAOA uVNTR polymorphism’s genotypes after a 6-week Fluvoxamine (SSRI) treatment in a Japanese population with MDD (p = 0.92).